Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults

A randomized, double-blind, phase 3 trial evaluated the immunogenicity, safety, and tolerability of a 13-valent pneumococcal conjugate vaccine (PCV13) coadministered with trivalent inactivated influenza vaccine (TIV) in pneumococcal vaccine-naive adults. Participants ages 50 to 59 years (n = 1,116)...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Frenck, Robert W., Gurtman, Alejandra, Rubino, John, Smith, William, van Cleeff, Martin, Jayawardene, Deepthi, Giardina, Peter C., Emini, Emilio A., Gruber, William C., Scott, Daniel A., Schmöle-Thoma, Beate
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2012
Sujets:
Vaccines
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3416075/
https://ncbi.nlm.nih.gov/pubmed/22739693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00176-12
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires